NEURVATI
LIVE

Serial Number

99610256

Owner

Neurvati Neurosciences, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Jan 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NEURVATI Trademark

Serial Number: 99610256

NEURVATI is a trademark filed by Neurvati Neurosciences, Inc. on January 22, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Neurvati Neurosciences, Inc. (4 trademarks)

230 Park Avenue, Suite 2830
New York, NY 10169

Entity Type: 03

Trademark Details

Filing Date

January 22, 2026

Registration Date

Not Registered

Goods & Services

Scientific research and development services, pharmaceutical research and development, and medical clinical research; medical research and development in the field of neuroscience; Clinical medical consultation; Software as a Service (SaaS) services featuring software for performing data analytics and market intelligence in the field of neuroscience

pharmaceutical and therapeutic medicinal preparations for the treatment of diseases and disorders affecting the brain and nervous system, namely, neurodegenerative, neuroinflammatory, neurovascular, neuro-oncology, neuromuscular, traumatic brain injury diseases and disorders, genetic diseases and disorders, movement disorders, epilepsy, pain, craniofacial pain, cognitive diseases and disorders, psychotic disorders, thought disorders, mood disorders, anxiety disorders, personality disorders, behavioral disorders, PTSD, sleep-wake disorders, and all symptomatology associated with disorders and diseases of the brain and nervous system

medical devices for the treatment of diseases and disorders of the brain and nervous system, namely, Medical devices for the delivery of pharmaceutical preparations for treatment of diseases and disorders of the brain and nervous system; Drug delivery pumps for medical use; Implantable drug delivery devices for treatment of neurological and psychiatric disorders; Medical devices for the enteral delivery of pharmaceutical preparations through feeding tubes; Medical devices for administering liquid pharmaceutical formulations via gastrostomy and nasogastric tubes; Medical devices for preparing pharmaceutical solutions and suspensions for medical administration; Medical devices for reconstituting pharmaceutical powders into liquid preparations for medical use; Medical devices for mixing and homogenizing pharmaceutical suspensions prior to administration; Medical apparatus, namely, software-controlled devices for the treatment of neurological and psychiatric disorders; Digital therapeutic devices for treatment of cognitive and behavioral disorders; Medical devices for delivering software based therapeutic interventions for neurological and psychiatric disorders; Medical devices for providing software controlled cognitive and behavioral therapy; Medical devices for monitoring, analyzing, and modulating neurological activity through digital therapeutic software; Medical devices for administering software driven treatment programs for cognitive, mood, and behavioral disorders; Medical devices for delivering software guided neuromodulation and behavioral therapy

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 9, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 9, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 9, 2026 CNRT
ASSIGNED TO EXAMINER
May 20, 2026 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2026 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 22, 2026 MAFR
NEW APPLICATION ENTERED
Jan 22, 2026 NWAP